2022
Perceptions of Transfusion Access and Hospice Among Patients with Advanced Hematologic Malignancies (RP525)
Odejide O, Huntington S, Hurley S, Kaufman R, Shi E, Johnson K, Tulsky J, Abel G. Perceptions of Transfusion Access and Hospice Among Patients with Advanced Hematologic Malignancies (RP525). Journal Of Pain And Symptom Management 2022, 63: 1111-1112. DOI: 10.1016/j.jpainsymman.2022.04.091.Peer-Reviewed Original ResearchHospice servicesBlood cancersHospice useHematologic malignanciesUtility scoresAdvanced hematologic malignanciesBlood cancer patientsCaregiver focus groupsAdult patientsBlood transfusionMedian ageCancer CenterCancer patientsAcute leukemiaHospice modelValue patientsMedical appointmentsCancer placesPatientsRespite careWeb-based surveyTransfusionCancerCognitive debriefingMalignancy
2020
Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers
Henckel C, Revette A, Huntington SF, Tulsky JA, Abel GA, Odejide OO. Perspectives Regarding Hospice Services and Transfusion Access: Focus Groups With Blood Cancer Patients and Bereaved Caregivers. Journal Of Pain And Symptom Management 2020, 59: 1195-1203.e4. PMID: 31926969, PMCID: PMC7239741, DOI: 10.1016/j.jpainsymman.2019.12.373.Peer-Reviewed Original ResearchConceptsQuality of lifeBlood cancer patientsHospice servicesBereaved caregiversBlood cancersCancer patientsInnovative care delivery modelsPerspectives of patientsCare delivery modelsFocus groupsHematologic oncologistsHospice useLife careTransfusionPatientsHospice settingsQOL domainsPotential associationOverall positive experienceCancerCaregiversLife expectancyLower ratesResearch assistantsDelivery model
2019
RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis
Zeidan AM, Zhu W, Stahl M, Wang R, Huntington SF, Giri S, Podoltsev NA, Gore SD, Ma X, Davidoff AJ. RBC transfusion independence among lower risk MDS patients receiving hypomethylating agents: a population-level analysis. Leukemia & Lymphoma 2019, 60: 3181-3187. PMID: 31170846, DOI: 10.1080/10428194.2019.1622700.Peer-Reviewed Original ResearchConceptsRBC transfusion independenceLR-MDS patientsTransfusion independenceHMA initiationRBC transfusionClinical effectivenessReal-life clinical effectivenessRed blood cell transfusionLower-risk myelodysplastic syndromesLow-risk MDS patientsRisk MDS patientsBlood cell transfusionRisk myelodysplastic syndromesHMA therapyLR-MDSCell transfusionMost patientsDisease courseMDS patientsMedicare databaseMyelodysplastic syndromePopulation-level estimatesLower oddsTransfusionPatients
2016
Platelet Disorders: Diagnostic Tests and Their Interpretations
Huntington S, O’Hara M, Bennett J. Platelet Disorders: Diagnostic Tests and Their Interpretations. 2016, 171-183. DOI: 10.1007/978-3-319-30352-9_16.Peer-Reviewed Original ResearchIntensive care unitCare unitIntensive care unit stayConcurrent illnessHospital mortalityUnit stayTreatable causeVenous thrombosisHemostatic abnormalitiesBlood productsNormal rangeClinical practiceThrombocytopeniaNormal platelet physiologyPatientsNormal individualsDiagnostic testsThrombocytosisNormal hemostasisIntensive unitPlatelet physiologyPlateletsAppropriate concernTransfusionThrombosis